Vasospasm immediately after lower extremity arterial bypass may represent an uncommon cause of early graft failure. We report a successful case of catheter-directed, intra-arterial continuous vasodilator infusion to salvage a bypass graft threatened by severe, refractory vasospasm after incomplete response to nicardipine, verapamil, and nitroglycerin boluses. A continuous nitroglycerin infusion was administered for 24 hours, by which time the vasospasm resolved. At 12 months postoperatively, the graft remained patent with normal results of vascular laboratory studies. This report demonstrates that in cases of refractory vasospasm after peripheral bypass, continuous vasodilator infusion can be an effective treatment to prevent early graft failure. (J Vasc Surg Cases and Innovative Techniques 2018;4:58-62.) Pathologic vasospasm can be caused by both physiologic and mechanical mechanisms, such as nonocclusive mesenteric ischemia, 1 medications, 2 local bone and soft tissue trauma, and direct vessel injury. 2-4 Vasospasm has been described in almost every vascular bed, most frequently after coronary artery bypass grafting, 5-8 microvascular anastomoses, 9,10 and renal-mesenteric bypass grafts. 11 Indeed, vasospasm is a common occurrence after arterial manipulation during surgery, particularly in the population of younger patients. 9,11 Acute vasospasm generally resolves during a few hours postoperatively with supportive measures, such as fluid resuscitation and electrolyte repletion; it rarely persists long enough to cause permanent deleterious effects. However, if persistent, refractory vasospasm is observed in the setting of a new arterial bypass, this may represent a special case in which bypass patency may be at risk. We describe a case of a lower extremity bypass that was acutely threatened by severe refractory vasospasm and was successfully salvaged with catheter-directed, intra-arterial infusion of vasodilators during a 24-hour period. The patient provided consent for this case report, and it was exempt from Institutional Review Board approval at our institution.
Pathologic vasospasm can be caused by both physiologic and mechanical mechanisms, such as nonocclusive mesenteric ischemia, 1 medications, 2 local bone and soft tissue trauma, and direct vessel injury. [2] [3] [4] Vasospasm has been described in almost every vascular bed, most frequently after coronary artery bypass grafting, [5] [6] [7] [8] microvascular anastomoses, 9, 10 and renal-mesenteric bypass grafts. 11 Indeed, vasospasm is a common occurrence after arterial manipulation during surgery, particularly in the population of younger patients. 9, 11 Acute vasospasm generally resolves during a few hours postoperatively with supportive measures, such as fluid resuscitation and electrolyte repletion; it rarely persists long enough to cause permanent deleterious effects. However, if persistent, refractory vasospasm is observed in the setting of a new arterial bypass, this may represent a special case in which bypass patency may be at risk. We describe a case of a lower extremity bypass that was acutely threatened by severe refractory vasospasm and was successfully salvaged with catheter-directed, intra-arterial infusion of vasodilators during a 24-hour period. The patient provided consent for this case report, and it was exempt from Institutional Review Board approval at our institution.
CASE REPORT
A 44-year-old man presented to our institution several hours after suffering a low-velocity gunshot wound to the distal calf.
The distal tibia and fibula were fractured, displaced, and unstable. On neurovascular evaluation, the foot was insensate with diminished motor function, and no palpable pulses or Doppler signals were obtainable distal to the injury. The decision was made to proceed to the operating room for combined vascular evaluation and orthopedic stabilization.
Two proximal tibial and one transcalcaneal fixator pins were placed, and an A-frame external fixation was fashioned to minimize interference with potential tibial arterial access. After reduction and external fixation, lower extremity arteriography was performed through contralateral common femoral artery access. This demonstrated normal arterial inflow but cessation of flow in all three tibial arteries at the site of the bullet track, consistent with injury of all three tibial arteries (Fig 1) . Given the patient's sensory and motor deficits as well as the concern that these deficits may be attributed to ischemia, we thought urgent revascularization of the foot was necessary.
As this was a traumatic injury and the inflow vessels were otherwise normal, we elected to perform a tibial-pedal bypass with a short graft, as is our standard practice for traumatic injuries.
Contralateral proximal great saphenous vein was harvested. The posterior tibial (PT) artery was exposed in the midcalf through a standard medial approach. The distal PT artery was exposed posterior and inferior to the medial malleolus. A curved Kelly-Wick tunneler was used to fashion a subcutaneous tunnel around the soft tissue defect from the bullet track. Arterial clamping was performed 1 to 2 cm proximal and distal to the arteriotomies with Yasargil clips. The great saphenous vein was reversed, and bypass was performed between the arterial access points.
Immediately after completion of the bypass, the distal pulse was weak, so we performed completion angiography, which revealed sluggish flow in the graft and a string-of-beads appearance just before the proximal anastomosis, potentially consistent with clamp-related spasm (Fig 2) . The graft anastomoses were free of stenosis. A 3-mm angioplasty balloon was used in an attempt to treat the focal area of string-of-beads spasm, but Postoperatively, the patient's vascular examination findings declined to the point that 6 hours later, there was no pulse in the graft and no distal Doppler signals despite fluid resuscitation that maintained adequate urine output and systolic blood pressure. Given the concern for early graft failure, he was taken back to the operating room for arteriography. This revealed severe vasospasm of the inflow and outflow PT and a patent bypass graft with worsening sluggish flow (Fig 3) . The graft appeared to be at imminent risk of failure. We thought that further endovascular mechanical strategies, such as balloon angioplasty, would be of limited value or counterproductive and that medical treatment of vasospasm would likely be of more benefit. 
DISCUSSION
This report demonstrates successful prolonged, catheter-directed, intra-arterial vasodilator infusion used to salvage a bypass graft threatened by vasospasm. Numerous drugs and mixtures of drugs have been used to treat vasospasm; however, there is no conclusive evidence demonstrating the advantage of any particular medication or cocktail of medications over others. 7, 9 Vasodilator use during arterial interventions has been well described in a number of scenarios. In the coronary bypass and microsurgical literature, topical vasodilators have been used to maintain graft patency. [6] [7] [8] [9] [10] In the cardiac literature, directed radial arterial vasodilator injection has been used to facilitate sheath insertion or to assist with radial artery harvesting.
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Fig 3. Arteriogram 6 hours after bypass. Six hours postoperatively, there was no graft pulse and no distal arterial signals, prompting concern for graft failure. However, arteriography demonstrated a patent bypass with no anastomotic stenosis with sluggish flow due to worsening diffuse vasospasm involving all three tibial arteries. PT, Posterior tibial.
Vasospasm has also commonly been described in the renal and mesenteric arteries, especially after arterial bypass 11 or in the setting of nonocclusive mesenteric ischemia. 1 In both settings, it has classically been described as having a "string-of-sausages" appearance on arteriography with alternating stenoses and dilations. The mainstay of treatment is to correct the underlying cause with fluid administration, optimization of cardiac output, and elimination of vasopressors. In refractory cases, vasodilator infusion with papaverine, nitroglycerin, and prostaglandins has been described, but experience has been largely anecdotal, and the dose, duration, and selection of drugs have not been standardized. 14, 15 To treat the vasospasm in our case, we used the protocol of the aggressive treatment arm of the Intra-arterial Vasospasm Trial (IVT), 16 a trial investigating pharmacologic modalities for alleviating cerebral vasospasm after subarachnoid hemorrhage. While medications and dosages used were co-opted from the neurointerventional literature on cerebral vasospasm, 16 the applicability of these vasodilators to other vascular beds, including those of the lower extremity, appears to be valid. If the IVT study demonstrates superiority of a multidrug cocktail for cerebral vasospasm, it is reasonable to use such a strategy for critical vasospasm in other vascular beds in which such events are too rare to anticipate substantial high-level evidence to guide therapy. Others have reported treatment of acute peripheral vasospasm with directed intra-arterial injection of bolus vasodilators. 17 Continuous vasodilator infusion has been previously described in case reports for treatment of refractory cerebral vasospasm due to subarachnoid hemorrhage. 18, 19 However, our report of a continuous catheter-directed, intra-arterial vasodilator infusion for many hours to treat refractory vasospasm after a peripheral surgical bypass is novel. Our patient demonstrated a partial response to on-table high-dose intra-arterial bolus vasodilator administration; however, the response was incomplete and transitory and potentially inconsistent with maintenance of bypass patency. Although balloon angioplasty has been demonstrated to be safe and effective for the treatment of vasospasm in the cerebral circulation and the lower extremity, it was not effective for our patient. 2, 20 In addition, heparin infusion through the sheath was performed in our patient as an adjunct to vasodilator infusion to prevent thrombosis of the catheter and sheath. Vasospasm after arterial bypass is commonly transitory and resolves over several hours with conservative measures, such as adequate fluid resuscitation, and correction of acidosis and electrolyte imbalance. Before vasospasm is treated as the cause of poor graft flow, it is critical to first rule out and to correct any fixed mechanical obstruction, such as graft kinking or compression, flow-limiting dissection, clamp injury, or anastomotic stenosis. The traditional teaching of orthopedic reduction and fixation before arterial bypass is performed is useful as long as it does not delay vascular repair because fracture reduction may improve blood flow and obviate the need for arterial reconstruction, and getting the extremities to appropriate length is critical to constructing the appropriate conduit length. Also, temporary anticoagulation with a heparin infusion can be considered to prevent graft thrombosis when vasospasm is severe. 21 Although the presence of refractory vasospasm severe enough to threaten a bypass is rare, the contribution of vasospasm to acute postoperative graft failure may be under-recognized. When such cases are identified and bolus vasodilators alone appear to be an insufficient treatment, the option of catheter-directed vasodilator infusion should be considered.
